According to a recent study, 50% of GBM patients’ biopsies exhibit high levels of NG2/CSPG4 expression, which is linked to EGFR gene amplification (p = 0.0005) and a worse prognosis [101]. The gene discussed is EGFR; the disease is glioblastoma.